MARIA C. VILLA-MORALES

Improved identification of T‐ALL paediatric patients with low MRD but poor prognosis using a transcriptional signature

British Journal of Haematology

Jan 2025

journal-article

PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL

Npj Precision Oncology

Jan 2024

journal-article

The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib

Molecular Carcinogenesis

Jan 2024

journal-article

The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib

Molecular Carcinogenesis

Jan 2024

journal-article

PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL

npj Precision Oncology

Jan 2024

journal-article

SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms

British Journal of Haematology

Jan 2023

journal-article

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia

International Journal of Molecular Sciences

Jan 2023

journal-article

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia

International Journal of Molecular Sciences

Jan 2023

journal-article

Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

Nature Communications

Jan 2023

journal-article

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia

International Journal of Molecular Sciences

Jan 2023

journal-article

Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

Nature Communications

Jan 2023

journal-article

Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T‐ALL

British Journal of Haematology

Jan 2023

journal-article

Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL

British Journal of Haematology

Jan 2023

journal-article

SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T‐cell neoplasms

British Journal of Haematology

Jan 2023

journal-article

A Dual Role for FADD in Human Precursor T-Cell Neoplasms

International Journal of Molecular Sciences

Jan 2022

journal-article

A Dual Role for FADD in Human Precursor T-Cell Neoplasms

International Journal of Molecular Sciences

Jan 2022

journal-article

Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells

Carcinogenesis

Jan 2020

journal-article

Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma

Oncogene

Jan 2019

journal-article

Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells

Carcinogenesis

Jan 2019

journal-article

Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma

Scientific Reports

Jan 2019

journal-article

Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma

Scientific Reports

Jan 2019

journal-article

Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.

Oncogene

Jan 2019

journal-article

Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma

Oncogene

Jan 2019

journal-article

FADD in cancer: Mechanisms of altered expression and function, and clinical implications

Cancers

Jan 2019

journal-article

FADD in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications

Cancers

Jan 2019

journal-article

S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma

Carcinogenesis

Jan 2019

journal-article

S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma.

Carcinogenesis

Jan 2019

journal-article

S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma

Carcinogenesis

Jan 2019

journal-article

RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas

BMC Cancer

Jan 2018

journal-article

Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development

Leukemia

Jan 2016

journal-article

Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma

Oncotarget

Jan 2016

journal-article

Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma

Oncotarget

Jan 2016

journal-article

Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development.

Leukemia

Jan 2016

journal-article

Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer

Jnci-Journal of the National Cancer Institute

Jan 2015

journal-article

Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer

Journal of the National Cancer Institute

Jan 2015

journal-article

FAS system deregulation in T-cell lymphoblastic lymphoma

Cell Death and Disease

Jan 2014

journal-article

FAS system deregulation in T-cell lymphoblastic lymphoma

Cell Death & Disease

Jan 2014

journal-article

FAS system deregulation in T-cell lymphoblastic lymphoma.

Jan 2014

journal-article

Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development

Carcinogenesis

Jan 2013

journal-article

Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development

Carcinogenesis

Jan 2013

journal-article

Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development.

Jan 2013

journal-article

Targeting the Fas/FasL signaling pathway in cancer therapy

Expert Opinion on Therapeutic Targets

Jan 2012

journal-article

Targeting the Fas/FasL signaling pathway in cancer therapy

Expert Opinion on Therapeutic Targets

Jan 2012

journal-article

EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas

Carcinogenesis

Jan 2012

journal-article

EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas.

Jan 2012

journal-article

EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas

Carcinogenesis

Jan 2012

journal-article

Targeting the Fas/FasL signaling pathway in cancer therapy.

Jan 2012

journal-article

The effectiveness of Fas apoptosis signalling pathway determined by the combined action of functional polymorphisms at Fas, FasL and Fadd

Ejc Supplements

Jan 2010

journal-article

The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with γ-radiation-induced T-cell lymphoblastic lymphomas.

Jan 2010

journal-article

Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility

Carcinogenesis

Jan 2010

journal-article

Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility.

Jan 2010

journal-article

Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility

Carcinogenesis

Jan 2010

journal-article

Oncogenic function of smoothened in T-cell lymphoblastic lymphomas

Ejc Supplements

Jan 2010

journal-article

The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with gamma-radiation-induced T-cell lymphoblastic lymphomas

Oncogene

Jan 2010

journal-article

The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with γ-radiation-induced T-cell lymphoblastic lymphomas

Oncogene

Jan 2010

journal-article

A role for auxiliary TGF-beta receptor endoglin as a modulator of tumor progression

Ejc Supplements

Jan 2009

journal-article

A role for stroma-derived annexin A1 as mediator in the control of genetic susceptibility to T-cell lymphoblastic malignancies through prostaglandin E2 secretion.

Jan 2009

journal-article

A role for stroma-derived annexin A1 as mediator in the control of genetic susceptibility to T-cell lymphoblastic malignancies through prostaglandin e 2 secretion

Cancer Research

Jan 2009

journal-article

A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E-2 Secretion

Cancer Research

Jan 2009

journal-article

Cd274/Pdc1I1 as a genetic modifier controlling aggressiveness of T-cell lymphoblastic lymphoma

Ejc Supplements

Jan 2009

journal-article

Modulation of the susceptibility to T cell lymphoblastic lymphoma by Fas/FasL system: functional polymorphisms at Fas, FasL and Fadd

Ejc Supplements

Jan 2009

journal-article

Genetically modified mouse models in cancer studies

Clinical and Translational Oncology

Jan 2008

journal-article

Genetically modified mouse models in cancer studies.

Jan 2008

journal-article

Genetically modified mouse models in cancer studies

Clinical & Translational Oncology

Jan 2008

journal-article

A Role for the Fas/FasL System in Modulating Genetic Susceptibility to T-Cell Lymphoblastic Lymphomas

Cancer Research

Jan 2007

journal-article

A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas.

Jan 2007

journal-article

A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas

Cancer Research

Jan 2007

journal-article

A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis

Cancer Research

Jan 2007

journal-article

A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis

Cancer Research

Jan 2007

journal-article

A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas

Ejc Supplements

Jan 2007

journal-article

A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis.

Jan 2007

journal-article

Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to γ-radiation-induced thymic lymphoma

Oncogene

Jan 2006

journal-article

Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma.

Jan 2006

journal-article

Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma

Oncogene

Jan 2006

journal-article

Lack of correlation between DNA copy number and mRNA expression levels of c-myc in gamma-radiation-induced mouse thymic lymphomas by using quantitative real-time PCR.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Jan 2006

journal-article

MARIA C. VILLA-MORALES

Work

Universidad Autónoma de Madrid

Universidad Autónoma de Madrid, Facultad de Ciencias

Publications

Improved identification of T‐ALL paediatric patients with low MRD but poor prognosis using a transcriptional signature

PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL

The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib

The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib

PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL

SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia

Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia

Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T‐ALL

Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL

SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T‐cell neoplasms

A Dual Role for FADD in Human Precursor T-Cell Neoplasms

A Dual Role for FADD in Human Precursor T-Cell Neoplasms

Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells

Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma

Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells

Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma

Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma

Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.

Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma

FADD in cancer: Mechanisms of altered expression and function, and clinical implications

FADD in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications

S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma

S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma.

S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma

RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas

Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development

Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma

Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma

Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development.

Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer

Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer

FAS system deregulation in T-cell lymphoblastic lymphoma

FAS system deregulation in T-cell lymphoblastic lymphoma

FAS system deregulation in T-cell lymphoblastic lymphoma.

Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development

Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development

Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development.

Targeting the Fas/FasL signaling pathway in cancer therapy

Targeting the Fas/FasL signaling pathway in cancer therapy

EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas

EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas.

EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas

Targeting the Fas/FasL signaling pathway in cancer therapy.

The effectiveness of Fas apoptosis signalling pathway determined by the combined action of functional polymorphisms at Fas, FasL and Fadd

The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with γ-radiation-induced T-cell lymphoblastic lymphomas.

Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility

Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility.

Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility

Oncogenic function of smoothened in T-cell lymphoblastic lymphomas

The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with gamma-radiation-induced T-cell lymphoblastic lymphomas

The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with γ-radiation-induced T-cell lymphoblastic lymphomas

A role for auxiliary TGF-beta receptor endoglin as a modulator of tumor progression

A role for stroma-derived annexin A1 as mediator in the control of genetic susceptibility to T-cell lymphoblastic malignancies through prostaglandin E2 secretion.

A role for stroma-derived annexin A1 as mediator in the control of genetic susceptibility to T-cell lymphoblastic malignancies through prostaglandin e 2 secretion

A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E-2 Secretion

Cd274/Pdc1I1 as a genetic modifier controlling aggressiveness of T-cell lymphoblastic lymphoma

Modulation of the susceptibility to T cell lymphoblastic lymphoma by Fas/FasL system: functional polymorphisms at Fas, FasL and Fadd

Genetically modified mouse models in cancer studies

Genetically modified mouse models in cancer studies.

Genetically modified mouse models in cancer studies

A Role for the Fas/FasL System in Modulating Genetic Susceptibility to T-Cell Lymphoblastic Lymphomas

A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas.

A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas

A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis

A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis

A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas

A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis.

Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to γ-radiation-induced thymic lymphoma

Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma.

Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma

Lack of correlation between DNA copy number and mRNA expression levels of c-myc in gamma-radiation-induced mouse thymic lymphomas by using quantitative real-time PCR.